Standard of Care Treatment and Management

Currently, there is no cure or disease-modifying therapy that can stop or reverse the progression of Dentatorubral-pallidoluysian atrophy (DRPLA) ^[1]. However, this does not mean there is nothing to be done. Care focuses on “supportive management”—treating each symptom individually to improve quality of life, maintain safety, and provide comfort for both you and your caregivers ^[2].

Because DRPLA affects so many different systems in the body, it is best managed by a multidisciplinary team. This team typically includes a neurologist (often one specializing in movement disorders or epilepsy), a psychiatrist, a physical therapist, a speech-language pathologist, and a dietitian ^[3][4].

Managing Seizures and Myoclonus

Controlling seizures and the brief, shock-like muscle jerks known as myoclonus is a top priority, especially for those with juvenile-onset DRPLA ^[5].

• Anti-Seizure Medications: Because DRPLA is so rare, evidence for specific medications is limited mostly to case reports and small series. Medications like perampanel and levetiracetam have been used to manage DRPLA-related seizures ^[5]. In some reported cases, perampanel has been shown to reduce the frequency of severe seizures and even help with myoclonus ^[6]. However, these medications can have significant side effects, including mood or behavioral changes (such as irritability or aggression), which must be carefully monitored, especially in patients who already experience psychiatric symptoms.
• A Note on Sodium-Channel Blockers: Some traditional seizure medications (sodium-channel blockers) may be less effective or, in some instances, could potentially worsen certain types of myoclonus. Your doctor will carefully choose medications that are best suited for your specific seizure pattern ^[5]. Never start, stop, or change an antiseizure medication without consulting your treating neurologist.
• Surgical Options: In rare, exceptional cases where medications fail to control life-threatening seizures, highly specialized surgical procedures like a corpus callosotomy—which disconnects the two halves of the brain—have been attempted ^[7]. This is not a standard DRPLA treatment, but an individualized option with meaningful risks evaluated case-by-case by expert epilepsy centers.

Addressing Psychiatric and Behavioral Symptoms

Psychiatric symptoms, including psychosis (delusions or hallucinations) and personality changes, can occur at any age of onset ^[8].

• Medication: Small case reports suggest that low doses of “atypical” antipsychotic medications, such as quetiapine or olanzapine, may improve delusions and hallucinations in some patients ^[8][9].
• Balance and Risks: These medications must be managed very carefully by a clinician. They carry risks of sedation, orthostatic hypotension (drops in blood pressure), falls, metabolic changes, and worsening of ataxia or other movement symptoms ^[10]. If there are new hallucinations, severe agitation, suicidal thoughts, or an inability to maintain basic safety, seek urgent clinical evaluation immediately.

Mobility, Spasticity, and Pain

As DRPLA progresses, muscles may become stiff (spasticity) or experience involuntary contractions (dystonia), which can be painful and limit movement ^[11].

• Rehabilitation: Physical and occupational therapy are essential for maintaining range of motion, preventing painful joint “freezing” (contractures), and selecting equipment like walkers or specialized wheelchairs ^[4][12].
• Advanced Interventions: For very severe spasticity that does not respond to oral medications, an intrathecal baclofen pump—a device that delivers medication directly into the fluid around the spinal cord—has been occasionally used ^[11]. Like callosotomy, this is a rare, invasive intervention with significant risks, considered only after extensive specialist evaluation.

Swallowing and Nutrition

One of the most critical aspects of long-term care is managing dysphagia (difficulty swallowing). Over time, the muscles used for swallowing can weaken, leading to a high risk of aspiration pneumonia—when food or liquid enters the lungs instead of the stomach ^[12][13].

• Monitoring: Regular swallow evaluations by a speech-language pathologist, often using imaging like a FEES (Fiberoptic Endoscopic Evaluation of Swallowing) or a “barium swallow,” are used to detect silent aspiration ^[3][14].
• Enteral Nutrition (Tube Feeding): As swallowing becomes unsafe, a feeding tube, such as a G-tube or PEG tube, is frequently discussed. In one natural-history cohort, a large majority of patients eventually utilized enteral nutrition ^[12].
• Why it’s used: Tube feeding helps ensure you receive reliable hydration, nutrition, and a safe route for medications. It is important to know that a feeding tube does not completely prevent aspiration, as individuals can still aspirate their own saliva or experience stomach reflux ^[15]. For many families, deciding on a feeding tube is an individualized, shared decision based on the patient’s goals and ability to continue safe oral intake ^[12].

Planning for the Future

Because DRPLA is progressive, “advance care planning” is a vital part of standard management. This means having conversations with your family and doctors early on about your preferences for treatments like feeding tubes, breathing support, and emergency seizure care ^[1][4]. These discussions are not about giving up; they are about ensuring your care remains aligned with your values and goals as your needs change.